Different approaches to partner notification in primary care

Recruiting

You are on the General Public view
  • Source

    -
    Public Title Different approaches to partner notification in primary care
    Acronym N/A
    Source of Record URL http://isrctn.org/ISRCTN24160819
  • Trial

    -
    Health Condition(s) or Problem Sexually transmitted infections (STIs)
    Lay Summary Sorry, not currently available
    Who can enter the trial Practices: 1. Practices from the MRC General Practice Research Framework (GPRF), the South East Primary Care Research Network (PCRN-SE) or the Primary Care Research Network Greater London (PCRN-GL) 2. Registered populations of 5000 or more 3. A maximum of six practices considering themselves as "student health centres" will be recruited, and no more than four regarding themselves as running "locally enhanced services for sexual health" Individuals: 1. Belonging to the target population above 2. Over the age of 16 years (either sex) at the time of first attendance for this problem, or of screening for chlamydia (NB patients will be eligible if they refuse to communicate with partners, given the objectives of the study)
    Who cannot enter the trial Patients: 1. Learning difficulties 2. Unable to read trial materials after discussion with clinical staff 3. No means of communication acceptable to the patient for him/herself
    What will happen We will compare three different interventions in partner treatment: 1. Patient referral: patients are given information about their infection, and asked to tell their partner about the problem and the need to be treated 2. Contract referral: in addition to point 1 above, patients will be asked to agree to a specialist health adviser (contact tracing expert) to inform partner(s) if this has not been done after an agreed period of time (usually two days) 3. Provider referral: in addition to point 1 above, patients will be asked to agree to a specialist health adviser contacting one or more of their partner(s) at the time of diagnosis Treatment is a communication process without a defined duration. Follow up will be 10 - 12 weeks.
    Primary aim 1. Number of main partners per index patient treated for chlamydia and/or gonorrhoea/nonspecific urethritis/pelvic inflammatory disease 2. Proportion of index patients testing negative for the relevant STI at 3 months
    Secondary Aim 1. Number of partners per index patient presenting for treatment 2. Proportion of index patients having at least one partner treated 3. Number of main, casual and ex-partners per index patient tested for the relevant STI 4. Number of main, casual and ex-partners testing positive for the relevant STI 5. Number of index patients tested for HIV by 3 months 6. Number of current partners tested for HIV by 3 months 7. Time to definitive treatment of index patient for the relevant STI 8. Time to definitive treatment of current partner for the relevant STI 9. Uptake by index patients of "contract" and "provider" referral for one or more partners, within the relevant randomised groups 10. Patient-related factors impacting on partner notification or STI disclosure to main, casual and ex-partners An important secondary aim is to identify what patient-related or psychological factors impact on disclosure.
    Participant Information Sheet Not available in web format, please use the contact details below to request a patient information sheet
    Website Sorry, not currently available
    Recruitment Status Recruiting
    Nation England
    Location Brighton
  • Contact

    -
    Contact for Public Queries Prof Jackie Cassell Brighton and Sussex Medical School Chair in Primary Care Epidemiology Division of Primary Care and Public Health Room 320, Mayfied House University of Brighton Brighton BN1 9PU United Kingdom +44 (0)1273 641924 +44 (0)1273 644440 j.cassell@bsms.ac.uk
    Contact for Scientific Queries Sorry, not currently available
Please note:
  1. The UKCTG information is designed to inform you of existing trials. If you wish to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.
  2. The UKCTG is not responsible for the quality of the data displayed in the Gateway but can contact the data providers. Please contact us if you have any query regarding the quality of trial records.